Watson news

Watson Pharma (WPI) and Elan Settle Lawsuit Related to Generic Naprelan(R) Tablets

Paladin Files New Drug Submission for TRELSTAR ® 6 Month

Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium

Watson Pharma To Pay $18M To Elan To Settle Patent Suit

Wall Street Journal - 21 minutes ago
Watson Pharmaceuticals Inc. (WPI) will pay $18 million to Elan Corp. PLC (ELN) to settle patent litigation related to Watson's generic version of Naprelan, or naproxen sodium, tablets. In August ...

Gurus Buy Drugs and Bullets

Forbes - 57 minutes ago
The M100 like Watson Pharmaceuticals and Olin but decide it's time to jump ship at Royal Caribbean. Regardless of how tough times get, consumers can't afford to stop buying the basics: food ...

Goldman reaffirms 'Sell' rating on Watson

MSN Money - 29 minutes ago
NEW YORK (AP) - Shares of Watson Pharmaceuticals Inc. fell Monday after a Goldman Sachs analyst reaffirmed a "Sell" rating and his view that the drugmaker could face a downturn because of several ...

Watson to Present at Barclays Capital Global Healthcare Conference

CNNMoney.com - 19 minutes ago
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and ...

Seven Summits Research Releases Alerts on AMGN, KO, UNP, HANS, and WPI

10-K: WATSON PHARMACEUTICALS INC

Trade Alerts: WFMI, WPI, PDE, GME, WMB, APA